سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Inferior Frontal-Occipital Fasciculus (IFOF) is the Main Neural Pathway in Psychotic Symptoms Induced by Methamphetamine Abuse: A Tract-based Spatial Statistics Study

Publish Year: 1401
Type: Journal paper
Language: English
View: 224

This Paper With 5 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_IJHS-8-4_001

Index date: 17 February 2024

Inferior Frontal-Occipital Fasciculus (IFOF) is the Main Neural Pathway in Psychotic Symptoms Induced by Methamphetamine Abuse: A Tract-based Spatial Statistics Study abstract

Background: Chronic methamphetamine abuse can lead to white matter changes and increased levels of psychotic symptoms. This study aimed to investigate which neural pathway is most associated with the psychological symptoms of chronic Methamphetamine abuse.Methods: We recruited 42 chronic methamphetamine abuse subjects meeting DSM-5 criteria and 21 healthy controls. Psychotic signs were measured using the positive and negative syndrome scale (PANSS). We applied tract-based spatial statistics (TBSS) to investigate group differences in alteration DTI parameters and their association with psychotic symptoms.Results: Chronic methamphetamine abuse group had significantly lower FA and higher AD, RD, and MD in a wide range of white matter mainly IFOF, and subjects in the methamphetamine abuse group had significantly higher PANSS total scores when compared to the control group.Conclusions: Chronic methamphetamine abuse shows subtle patterns of impaired white matter integrity of distinct cerebral nerve pathways, mainly IFOF relative to controls. The results are further suggested that neuronal tract-based pathology plays the main role in psychotic symptoms in methamphetamine abuse disorders.Keywords: Methamphetamine, psychotic symptoms, Tract-Based Spatial Statistics (TBSS), Inferior Frontal-Occipital Fasciculus (IFOF).Background: Chronic methamphetamine abuse can lead to white matter changes and increased levels of psychotic symptoms. This study aimed to investigate which neural pathway is most associated with the psychological symptoms of chronic Methamphetamine abuse. Methods: We recruited 42 chronic methamphetamine abuse subjects meeting DSM-5 criteria and 21 healthy controls. Psychotic signs were measured using the positive and negative syndrome scale (PANSS). We applied tract-based spatial statistics (TBSS) to investigate group differences in alteration DTI parameters and their association with psychotic symptoms. Results: Chronic methamphetamine abuse group had significantly lower FA and higher AD, RD, and MD in a wide range of white matter mainly IFOF, and subjects in the methamphetamine abuse group had significantly higher PANSS total scores when compared to the control group. Conclusions: Chronic methamphetamine abuse shows subtle patterns of impaired white matter integrity of distinct cerebral nerve pathways, mainly IFOF relative to controls. The results are further suggested that neuronal tract-based pathology plays the main role in psychotic symptoms in methamphetamine abuse disorders. Keywords: Methamphetamine, psychotic symptoms, Tract-Based Spatial Statistics (TBSS), Inferior Frontal-Occipital Fasciculus (IFOF).

Inferior Frontal-Occipital Fasciculus (IFOF) is the Main Neural Pathway in Psychotic Symptoms Induced by Methamphetamine Abuse: A Tract-based Spatial Statistics Study Keywords:

Methamphetamine , psychotic symptoms , Tract-Based Spatial Statistics (TBSS) , Inferior Frontal-Occipital Fasciculus (IFOF)

Inferior Frontal-Occipital Fasciculus (IFOF) is the Main Neural Pathway in Psychotic Symptoms Induced by Methamphetamine Abuse: A Tract-based Spatial Statistics Study authors

Javad Sheikhi Koohsar

Center for Health-Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran.

Salman Safdari

Department of Radiology Technology, School of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Milad Bazghale

Center for Health-Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran.

Sadegh Masjoodi

Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Alireza Azizi

Center for Health-Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran.

Hamid Kalalian Moghadam

School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.

Mohammad Niroumand Sarvandani

Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.